Literature DB >> 24265914

Commensal microbiota drive proliferation of conventional and Foxp3(+) regulatory CD4(+) T cells in mesenteric lymph nodes and Peyer's patches.

Sascha Cording, Diana Fleissner, Markus M Heimesaat, Stefan Bereswill, Christoph Loddenkemper, Satoshi Uematsu, Shizuo Akira, Alf Hamann, Jochen Huehn.   

Abstract

Compelling evidence demonstrates that intestinal commensal microbiota modulate conventional and regulatory T cell (Treg) responses that are required for effective host defence against pathogens and avoidance of autoimmunity and other immunopathologic conditions. Here, we investigated the contribution of the commensal microbiota and Toll-like receptor (TLR) signaling to homeostasis of Foxp3(-) conventional CD4(+) T cells and Foxp3(+) Tregs. Upon long-term antibiotics treatment, we observed a significant reduction of conventional CD4(+) T cell proliferation in a systemic manner, whereas Foxp3(+) Treg proliferation was locally impaired in gut-draining mesenteric lymph nodes and Peyer's patches. The proliferative response to microbial components was not mediated by TLRs as MyD88- and various TLR-deficient mice displayed normal or even increased conventional T cell and Foxp3(+) Treg proliferation. Thus, commensal microbiota-derived stimuli support cycling of both conventional CD4(+) T cells and Foxp3(+) Tregs with TLR-mediated recognition of bacterial components not being the major mechanism controlling microbiota-driven T cell homeostasis.

Entities:  

Keywords:  T cell homeostasis, commensal microbiota, antibiotics, Foxp3−CD4+ T cells, Foxp3+CD4+ Tregs, MyD88-deficient mice, TLR-deficient mice

Year:  2013        PMID: 24265914      PMCID: PMC3832078          DOI: 10.1556/EuJMI.3.2013.1.1

Source DB:  PubMed          Journal:  Eur J Microbiol Immunol (Bp)        ISSN: 2062-509X


  60 in total

Review 1.  The Toll receptor family and microbial recognition.

Authors:  R Medzhitov; C Janeway
Journal:  Trends Microbiol       Date:  2000-10       Impact factor: 17.079

2.  Demonstration of strong enterobacterial reactivity of CD4+CD25- T cells from conventional and germ-free mice which is counter-regulated by CD4+CD25+ T cells.

Authors:  Monika Gad; Anders Elm Pedersen; Nanna N Kristensen; Mogens H Claesson
Journal:  Eur J Immunol       Date:  2004-03       Impact factor: 5.532

Review 3.  The impact of perinatal immune development on mucosal homeostasis and chronic inflammation.

Authors:  Harald Renz; Per Brandtzaeg; Mathias Hornef
Journal:  Nat Rev Immunol       Date:  2011-12-09       Impact factor: 53.106

Review 4.  What immunologists should know about bacterial communities of the human bowel.

Authors:  Gerald W Tannock
Journal:  Semin Immunol       Date:  2006-10-10       Impact factor: 11.130

5.  Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12.

Authors:  R Duchmann; E Schmitt; P Knolle; K H Meyer zum Büschenfelde; M Neurath
Journal:  Eur J Immunol       Date:  1996-04       Impact factor: 5.532

6.  Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes.

Authors:  Christoph Kalis; Marina Gumenscheimer; Nikolaus Freudenberg; Sandrine Tchaptchet; György Fejer; Antje Heit; Shizuo Akira; Chris Galanos; Marina A Freudenberg
Journal:  J Immunol       Date:  2005-04-01       Impact factor: 5.422

7.  Toll-like receptor 2 controls expansion and function of regulatory T cells.

Authors:  Roger P M Sutmuller; Martijn H M G M den Brok; Matthijs Kramer; Erik J Bennink; Liza W J Toonen; Bart-Jan Kullberg; Leo A Joosten; Shizuo Akira; Mihai G Netea; Gosse J Adema
Journal:  J Clin Invest       Date:  2006-01-19       Impact factor: 14.808

Review 8.  Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation.

Authors:  Ana Izcue; Janine L Coombes; Fiona Powrie
Journal:  Immunol Rev       Date:  2006-08       Impact factor: 12.988

9.  Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function.

Authors:  Guangyong Peng; Zhong Guo; Yukiko Kiniwa; Kui Shin Voo; Weiyi Peng; Tihui Fu; Daniel Y Wang; Yanchun Li; Helen Y Wang; Rong-Fu Wang
Journal:  Science       Date:  2005-08-26       Impact factor: 47.728

10.  Engagement of TLR2 does not reverse the suppressor function of mouse regulatory T cells, but promotes their survival.

Authors:  Qian Chen; Todd S Davidson; Eva N Huter; Ethan M Shevach
Journal:  J Immunol       Date:  2009-09-11       Impact factor: 5.422

View more
  22 in total

1.  Enhanced renewal of regulatory T cells in relation to CD4(+) conventional T lymphocytes in the peripheral compartment.

Authors:  Jeane de Souza Nogueira; Fábio Barrozo do Canto; Caroline Fraga Cabral Gomes Nunes; Pedro Henrique Oliveira Vianna; Luciana de Souza Paiva; Alberto Nóbrega; Maria Bellio; Rita Fucs
Journal:  Immunology       Date:  2015-12-17       Impact factor: 7.397

2.  Parasite Proximity Drives the Expansion of Regulatory T Cells in Peyer's Patches following Intestinal Helminth Infection.

Authors:  Ilaria Mosconi; Lalit Kumar Dubey; Beatrice Volpe; Julia Esser-von Bieren; Mario M Zaiss; Luc Lebon; Joanna C Massacand; Nicola L Harris
Journal:  Infect Immun       Date:  2015-07-06       Impact factor: 3.441

3.  Uhrf to Treg cells: reinforcing the mucosal peacekeepers.

Authors:  Daniel H D Gray; Adrian Liston
Journal:  Nat Immunol       Date:  2014-06       Impact factor: 25.606

Review 4.  Modulation of autoimmune arthritis by environmental 'hygiene' and commensal microbiota.

Authors:  David Langan; Eugene Y Kim; Kamal D Moudgil
Journal:  Cell Immunol       Date:  2018-12-10       Impact factor: 4.868

5.  Long-term antibiotic exposure promotes mortality after systemic fungal infection by driving lymphocyte dysfunction and systemic escape of commensal bacteria.

Authors:  Rebecca A Drummond; Jigar V Desai; Emily E Ricotta; Muthulekha Swamydas; Clay Deming; Sean Conlan; Mariam Quinones; Veronika Matei-Rascu; Lozan Sherif; David Lecky; Chyi-Chia R Lee; Nathaniel M Green; Nicholas Collins; Adrian M Zelazny; D Rebecca Prevots; David Bending; David Withers; Yasmine Belkaid; Julia A Segre; Michail S Lionakis
Journal:  Cell Host Microbe       Date:  2022-05-13       Impact factor: 31.316

6.  An intact gut microbiome protects genetically predisposed mice against leukemia.

Authors:  Carolina Vicente-Dueñas; Stefan Janssen; Marina Oldenburg; Franziska Auer; Inés González-Herrero; Ana Casado-García; Marta Isidro-Hernández; Javier Raboso-Gallego; Philipp Westhoff; Aleksandra A Pandyra; Daniel Hein; Katharina L Gössling; Diego Alonso-López; Javier De Las Rivas; Sanil Bhatia; Francisco Javier García-Criado; María Begoña García-Cenador; Andreas P M Weber; Karl Köhrer; Julia Hauer; Ute Fischer; Isidro Sánchez-García; Arndt Borkhardt
Journal:  Blood       Date:  2020-10-29       Impact factor: 22.113

Review 7.  Roles of intestinal microbiota in response to cancer immunotherapy.

Authors:  Jing Cong; Xiaochun Zhang
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-09-12       Impact factor: 3.267

Review 8.  Intestinal microbiota as modulators of the immune system and neuroimmune system: impact on the host health and homeostasis.

Authors:  Carlos Magno da Costa Maranduba; Sandra Bertelli Ribeiro De Castro; Gustavo Torres de Souza; Cristiano Rossato; Francisco Carlos da Guia; Maria Anete Santana Valente; João Vitor Paes Rettore; Claudinéia Pereira Maranduba; Camila Maurmann de Souza; Antônio Márcio Resende do Carmo; Gilson Costa Macedo; Fernando de Sá Silva
Journal:  J Immunol Res       Date:  2015-02-22       Impact factor: 4.818

9.  Intestinal Peyer's patches prevent tumorigenesis in Apc (Min/+) mice.

Authors:  Kyoko Fujimoto; Gen Fujii; Hitomi Sakurai; Hiroko Yoshitome; Michihiro Mutoh; Morimasa Wada
Journal:  J Clin Biochem Nutr       Date:  2014-11-28       Impact factor: 3.114

10.  Intestinal mucosal tolerance and impact of gut microbiota to mucosal tolerance.

Authors:  Dimitry A Chistiakov; Yuri V Bobryshev; Emil Kozarov; Igor A Sobenin; Alexander N Orekhov
Journal:  Front Microbiol       Date:  2015-01-13       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.